Press release
Radioimmunoassays Market worth $612.00 million by 2030, growing at a CAGR of 4.49% - Exclusive Report by 360iResearch
Radioimmunoassays Market | 360iResearch
The Global Radioimmunoassays Market to grow from USD 430.39 million in 2022 to USD 612.00 million by 2030, at a CAGR of 4.49%.
Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/radioimmunoassays?utm_source=openpr&utm_medium=referral&utm_campaign=sample
FPNV Positioning Matrix:
The FPNV Positioning Matrix is essential for assessing the Radioimmunoassays Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).
Market Share Analysis:
The Market Share Analysis offers an insightful look at the current state of vendors in the Radioimmunoassays Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.
Key Company Profiles:
The report delves into recent significant developments in the Radioimmunoassays Market, highlighting leading vendors and their innovative profiles. These include Abbexa Limited, Abcam Plc, ALPCO, Antigenix America, Inc., Berthold Technologies GmbH & Co.KG, Biosynth Ltd, BioVendor - Laboratorni medicina a.s., Creative Biomart, Inc., Danaher Corporation, Demeditec Diagnostics GmbH, Diasorine S.P.A., DRG International, Inc. by BioCheck Inc., Drive DeVilbiss International, EUROIMMUN Medizinische Labordiagnostika AG, Hidex Oy., IBL International GmbH, Immuno-Biological Laboratories, Inc., Institute of Isotopes Co. Ltd., LKB Instruments, LubioScience GmbH, Marin Biologic Laboratories, Inc., Merck & Co, Inc, Montreal Biotech Inc., MP Biomedicals, LLC, NovoLytix GmbH, Padyab Teb Co., and PerkinElmer Inc..
Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/radioimmunoassays?utm_source=openpr&utm_medium=referral&utm_campaign=inquire
Market Segmentation & Coverage:
This research report categorizes the Radioimmunoassays Market in order to forecast the revenues and analyze trends in each of following sub-markets:
Based on Type, market is studied across Coated-Tube RIA and Double-Antibody RIA. The Double-Antibody RIA is projected to witness significant market share during forecast period.
Based on Product Type, market is studied across Analyzers and Reagents & Kits. The Analyzers is projected to witness significant market share during forecast period.
Based on Application, market is studied across Clinical Diagnostics and Research. The Clinical Diagnostics is projected to witness significant market share during forecast period.
Based on End-User, market is studied across Academic & Research Institutes, Clinical Diagnostic Laboratories, Hospitals, and Pharmaceuticals & CROs. The Clinical Diagnostic Laboratories is projected to witness significant market share during forecast period.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Asia-Pacific is projected to witness significant market share during forecast period.
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Radioimmunoassays Market, by Type
7. Radioimmunoassays Market, by Product Type
8. Radioimmunoassays Market, by Application
9. Radioimmunoassays Market, by End-User
10. Americas Radioimmunoassays Market
11. Asia-Pacific Radioimmunoassays Market
12. Europe, Middle East & Africa Radioimmunoassays Market
13. Competitive Landscape
14. Competitive Portfolio
15. Appendix
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Radioimmunoassays Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Radioimmunoassays Market?
3. What is the competitive strategic window for opportunities in the Radioimmunoassays Market?
4. What are the technology trends and regulatory frameworks in the Radioimmunoassays Market?
5. What is the market share of the leading vendors in the Radioimmunoassays Market?
6. What modes and strategic moves are considered suitable for entering the Radioimmunoassays Market?
Read More @ https://www.360iresearch.com/library/intelligence/radioimmunoassays?utm_source=openpr&utm_medium=referral&utm_campaign=analyst
Contact 360iResearch
Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550
About 360iResearch
360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Radioimmunoassays Market worth $612.00 million by 2030, growing at a CAGR of 4.49% - Exclusive Report by 360iResearch here
News-ID: 3329827 • Views: …
More Releases from 360iResearch
Rising Incidence of Human Metapneumovirus in Vulnerable Populations Boosts Globa …
In recent years, the silent ascent of human metapneumovirus (HMPV) infections has begun to capture significant attention within the realm of infectious diseases. As we advance in medical science, unraveling complexities of age-old pathogens like common influenza or emerging illnesses like COVID-19, a critical discourse has been emerging around HMPV. Particularly, there seems to be a burgeoning acknowledgment of its growing impact on vulnerable global populations, propelling an increased demand…
The Meat Alternatives Market size was estimated at USD 9.39 billion in 2023 and …
From Appetite to Advocacy: The Rising Demand for Meat Alternatives
In recent years, the global food industry has been undergoing a remarkable transformation, driven primarily by an increasing consumer demand for healthier, sustainable, and ethically sourced food products. This seismic shift has brought traditional meat alternatives and high-protein plant-based foods into the spotlight. As the world becomes more conscious of the implications of meat consumption on health and the environment, the…
The Mobility-as-a-Service Market size was estimated at USD 264.80 billion in 202 …
Unpacking the Surge in Investments and Collaborations to Bolster Mobility-as-a-Service
In recent years, as urban landscapes continually evolve, a transformative shift known as Mobility-as-a-Service (MaaS) has reshaped the way we perceive transportation. Marked by the integration of various forms of transport services into a single accessible on-demand mobility solution, MaaS is rapidly gaining traction across global cities. As an emerging paradigm, it's not just shaping the future of travel but also…
The Data Center Services Market size was estimated at USD 56.65 billion in 2023 …
Smart City Revolutions: Why Data Center Colocation is the Future Backbone
In the era of digital transformation, urban landscapes across the globe are undergoing a seismic shift toward becoming "smart cities." The concept of a smart city revolves around using digital technology, IoT (Internet of Things), AI, and data analytics at an unprecedented scale to improve urban infrastructure, manage resources efficiently, and enhance the quality of life for citizens. A vital…
More Releases for Radioimmunoassays
Radioimmunoassays Market to Hit USD 564.65 Million by 2033 | Key Players: Beckma …
According to a newly published report by Fact.MR, the global radioimmunoassays market is poised for steady growth in the coming decade. Valued at USD 420.15 million in 2023, the market is projected to expand at a CAGR of 3%, reaching a valuation of USD 564.65 million by the end of 2033.
The market is witnessing rising demand from both clinical diagnostics and research laboratories, supported by advancements in immunoassay technologies and…
Radioimmunoassays Market Is Expected To Reach US$ 564.65 Million By 2033
The global radioimmunoassays market is valued at US$ 420.15 million in 2023 and is predicted to reach US$ 564.65 million by the end of 2033.
By administering a radiolabeled antigen and monitoring the ensuing radioactivity of the antibody component, a radioimmunoassay (RIA) is an in-vitro assay for estimating antibody levels. Solomon Berson and Rosalyn Yalow of the Boranx Veterans Administration Hospital in New York first described the RIA in the 1950s…
Immunodiagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis …
Growing Use of Point-of-Care Immunodiagnostics to Drive Immunodiagnostics Market
For sample pages and special offers, please visit https://www.thinkingcapsrc.com/reports/2341/immunodiagnostics-market
According to our new market research study on ""Immunodiagnostics Market to 2028 - Global Analysis and Forecast - by Product, Clinical Indication, and End User,"" the market is expected to grow from US$ 17,948.62 million in 2021 to US$ 29,526.72 million by 2028; it is expected to grow at a CAGR of 7.4% from…
Radioimmunoassays Market is expected to Exhibit a Massive CAGR of +7% by 2030 |I …
"A radioimmunoassay (RIA) is a biochemical assay that uses an radioactive tracer to measure the amount of a specific antigen in a sample. The assay is based on the principle of competitive binding, in which the radioactive tracer competes with the antigen for binding to a specific antibody. The amount of antigen in the sample is then determined by measuring the amount of radioactive tracer that is bound to the…
Radioimmunoassays Market Insights Covering Growing Market Dynamics and Competiti …
The latest competent intelligence report published by WMR with the title "An increase in demand and Opportunities for Global Radioimmunoassays Market 2022" provides a sorted image of the Radioimmunoassays industry by analysis of research and information collected from various sources that have the ability to help the decision-makers in the worldwide market to play a significant role in making a gradual impact on the global economy. The report presents and…
Immunoassay Market Worth $19.76 billion by 2025 With a CAGR of 5.9%, Hospitals, …
Meticulous Research?- leading global market research company published a research report titled "Immunoassay Market by Product (Kits & Reagents, Analyzers, Software), Platform (Chemiluminescence, Radioimmunoassays) Application (Infectious Diseases, Cardiology), End User (Hospitals, Academic Laboratories), and Geography - Global Forecast to 2025".
Download a Free Sample Report Now @
https://www.meticulousresearch.com/download-sample-report/cp_id=4982
According to this latest publication from Meticulous Research?, the global immunoassay market is expected to grow at a CAGR of 5.9% from 2019 to reach…
